U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2622126221Movement System Impairment Based Classification Versus General Exercise for Chronic Non-specific Low Back Pain: a Randomised Controlled TrialRecruitingNo Results AvailableLow Back PainOther: Treatment based on Movement System Impairment model|Other: General exercisehttps://ClinicalTrials.gov/show/NCT02221609
2622226222Vitamin D and Muscle Metabolic FunctionRecruitingNo Results AvailableHealthyDietary Supplement: vitamin D|Other: aerobic traininghttps://ClinicalTrials.gov/show/NCT02221596
2622326223Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve GastrectomyCompletedNo Results AvailableEnd Stage Renal DiseaseDrug: Astagraf XL|Drug: Prograf|Drug: Mycophenolate mofetilhttps://ClinicalTrials.gov/show/NCT02221583
2622426224Baclofen in the Treatment of Muscle Cramps in Patients With CirrhosisRecruitingNo Results AvailableMuscle Cramps|Liver CirrhosisDrug: Baclofenhttps://ClinicalTrials.gov/show/NCT02221570
2622526225Case Series of New Alloplastic Bone Graft MaterialRecruitingNo Results AvailablePeriodontology|Oral SurgeryDevice: easy-graft (beta-Tricalcium Phosphate)https://ClinicalTrials.gov/show/NCT02221557
2622626226The Effect of Low-frequency rTMS on Motor Function in PD Patients With Freezing of GaitNot yet recruitingNo Results AvailableParkinson's DiseaseDevice: Low-frequency repetitive Transcranial Magnetic Stimulation|Device: rTMS maintenance|Device: Sham|Device: Sham maintenancehttps://ClinicalTrials.gov/show/NCT02221544
2622726227Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioNRecruitingNo Results AvailableComplications; Cesarean Section|Anesthesia; ReactionDrug: Carbetocin Short-infusion|Drug: Carbetocin Bolus applicationhttps://ClinicalTrials.gov/show/NCT02221531
2622826228Control and Reward Circuits in Obsessive Compulsive DisorderRecruitingNo Results AvailableObsessive-Compulsive DisorderBehavioral: Exposure & Response Prevention (EX/RP)https://ClinicalTrials.gov/show/NCT02221518
2622926229Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid LeukemiaTerminatedNo Results AvailablecKIT-positive Solid Tumors|AMLDrug: LOP628https://ClinicalTrials.gov/show/NCT02221505
2623026230Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin LymphomaRecruitingNo Results AvailableLymphomaDrug: plerixafor GZ316455|Drug: Filgrastimhttps://ClinicalTrials.gov/show/NCT02221492
2623126231Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: plerixafor GZ316455|Drug: Filgrastimhttps://ClinicalTrials.gov/show/NCT02221479
2623226232Measurement of Endothelial Function With Peripheral Arterial Tonometry in Patients Undergoing Hyperbaric Oxygen TherapyRecruitingNo Results AvailableDiabetic Peripheral Vascular Diseasehttps://ClinicalTrials.gov/show/NCT02221466
2623326233Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone AcetonideNot yet recruitingNo Results AvailableDiabetic Macular EdemaDrug: Triamcinolone Acetonidehttps://ClinicalTrials.gov/show/NCT02221453
2623426234Maternal Oxygen Administration for Fetal DistressCompletedNo Results AvailableOxygen Inhalation Therapy|Second Stage of Labour|Fetal DistressDevice: Low flow nasal oxygenhttps://ClinicalTrials.gov/show/NCT02221440
2623526235The Labour Progression Study, a Cluster Randomised Trial on Labour Progression for First Time MothersRecruitingNo Results AvailableCaesarean Sections|Augmentation With Oxytocin|Labour DystociaOther: Dynamic progression curve|Other: Static labour progression curve (F)https://ClinicalTrials.gov/show/NCT02221427
2623626236Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Linagliptin/Metformin FDC|Drug: Linagliptin|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT02221414
2623726237Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Linagliptin/Metformin FDC|Drug: Linagliptin|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT02221401
2623826238Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: BI 671800 HEA, 200 mg tablets|Drug: BI 671800 HEA EC, 200 mg tablets|Drug: BI 671800 HEA, 50 mg tablets|Drug: BI 671800 ED, 100 mg capsules|Other: Standard mealhttps://ClinicalTrials.gov/show/NCT02221388
2623926239Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BHT low|Drug: BHT medium|Drug: BHT high|Drug: BI 54903 XX low|Drug: BI 54903 XX medium 1|Drug: BI 54903 XX medium 2|Drug: BI 54903 XX high|Drug: Ciclesonidehttps://ClinicalTrials.gov/show/NCT02221375
2624026240A Prospective, Noninterventional, Observational Study of Late-Onset Pompe DiseaseRecruitingNo Results AvailableLate-onset Pompe Patients Untreated or Treated With rhGAA.https://ClinicalTrials.gov/show/NCT02221362
2624126241A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral HygieneCompletedNo Results AvailableDentin SensitivityDevice: Potassium oxalate|Drug: Sodium fluoride paste|Drug: Stannous fluoride pastehttps://ClinicalTrials.gov/show/NCT02221349
2624226242Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II TrialRecruitingNo Results AvailableBipolar DisorderDevice: The MONARCA II systemhttps://ClinicalTrials.gov/show/NCT02221336
2624326243A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1CompletedNo Results AvailableDiabetes MellitusDrug: Insulin LISPROhttps://ClinicalTrials.gov/show/NCT02221323
2624426244Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDSRecruitingNo Results AvailableAcute Myelogenous Leukemia|Myelodysplastic SyndromeDrug: Gemtuzumab Ozogamicinhttps://ClinicalTrials.gov/show/NCT02221310
2624526245Lipid-lowering Effect of a Plant Stanol Ester Supplement ProductActive, not recruitingNo Results AvailableHypercholesterolemia|Hyperlipidemias|DyslipidemiasDietary Supplement: Supplement product with plant stanol esterhttps://ClinicalTrials.gov/show/NCT02221297
2624626246Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"RecruitingNo Results AvailableType 2 Diabetes MellitusDrug: Alogliptinhttps://ClinicalTrials.gov/show/NCT02221284
2624726247Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré SyndromeRecruitingNo Results AvailableGuillain-Barré SyndromeDrug: NPB-01https://ClinicalTrials.gov/show/NCT02221271
2624826248Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)RecruitingNo Results AvailableRheumatoid ArthritisBiological: FURESTEM-RA Inj.https://ClinicalTrials.gov/show/NCT02221258
2624926249Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During the Staging Ultrasound of Esophageal Cancer PatientsRecruitingNo Results AvailableEsophageal CancerProcedure: Tumor Biospy via Ultrasound Endoscopyhttps://ClinicalTrials.gov/show/NCT02221245
2625026250Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrepâ„¢TerminatedNo Results AvailableSurgical Site InfectionDrug: Chloraprep|Drug: ZuraPrep Config 1|Drug: ZuraPrep Config 2|Drug: Vehicle Producthttps://ClinicalTrials.gov/show/NCT02221232

* Görseller ve İçerik tekif hakkına sahip olabilir